NEO
Price
$5.18
Change
+$0.34 (+7.02%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
2.01B
101 days until earnings call
ZETA
Price
$15.08
Change
-$0.57 (-3.64%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
2.36B
4 days until earnings call
Interact to see
Advertisement

NEO vs ZETA

Header iconNEO vs ZETA Comparison
Open Charts NEO vs ZETABanner chart's image
NeoGenomics
Price$5.18
Change+$0.34 (+7.02%)
Volume$91.97K
Capitalization2.01B
Zeta Global Holdings
Price$15.08
Change-$0.57 (-3.64%)
Volume$44.83K
Capitalization2.36B
NEO vs ZETA Comparison Chart in %
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZETA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. ZETA commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a StrongBuy and ZETA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (NEO: $4.84 vs. ZETA: $15.65)
Brand notoriety: NEO and ZETA are both not notable
NEO represents the Medical Specialties, while ZETA is part of the Packaged Software industry
Current volume relative to the 65-day Moving Average: NEO: 195% vs. ZETA: 103%
Market capitalization -- NEO: $2.01B vs. ZETA: $2.36B
NEO [@Medical Specialties] is valued at $2.01B. ZETA’s [@Packaged Software] market capitalization is $2.36B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Packaged Software] industry ranges from $3.15T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B. The average market capitalization across the [@Packaged Software] industry is $12.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileZETA’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • ZETA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZETA is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 4 TA indicator(s) are bullish while ZETA’s TA Score has 2 bullish TA indicator(s).

  • NEO’s TA Score: 4 bullish, 5 bearish.
  • ZETA’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, NEO is a better buy in the short-term than ZETA.

Price Growth

NEO (@Medical Specialties) experienced а -24.61% price change this week, while ZETA (@Packaged Software) price change was -1.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.60%. For the same industry, the average monthly price growth was -2.18%, and the average quarterly price growth was -4.69%.

The average weekly price growth across all stocks in the @Packaged Software industry was -4.94%. For the same industry, the average monthly price growth was -3.18%, and the average quarterly price growth was +2.05%.

Reported Earning Dates

NEO is expected to report earnings on Nov 11, 2025.

ZETA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (-2.60% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Packaged Software (-4.94% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZETA($2.36B) has a higher market cap than NEO($2.01B). ZETA YTD gains are higher at: -13.007 vs. NEO (-70.631). NEO has higher annual earnings (EBITDA): -17.61M vs. ZETA (-124.36M). NEO has more cash in the bank: 415M vs. ZETA (132M). ZETA has less debt than NEO: ZETA (184M) vs NEO (612M). ZETA has higher revenues than NEO: ZETA (729M) vs NEO (592M).
NEOZETANEO / ZETA
Capitalization2.01B2.36B85%
EBITDA-17.61M-124.36M14%
Gain YTD-70.631-13.007543%
P/E Ratio49.50N/A-
Revenue592M729M81%
Total Cash415M132M314%
Total Debt612M184M333%
FUNDAMENTALS RATINGS
NEO: Fundamental Ratings
NEO
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEOZETA
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 22 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZETA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VFAIX64.40N/A
N/A
Vanguard Financials Index Admiral
PJGQX23.32N/A
N/A
PGIM Jennison Mid-Cap Growth R6
IGFAX11.93N/A
N/A
VY® Morgan Stanley Global Franchise A
SDYYX18.38N/A
N/A
SEI Dynamic Asset Allocation Y (SIMT)
AGLOX14.65-0.05
-0.34%
Ariel Global Investor